Inocell

Inositol Hexaphosphate (IP₆) is also known as myo-inositol hexaphosphate an all natural substance and very safe.
IP₆ is found in substantial amounts in whole grains, cereals, legumes, nuts and seeds and is the primary energy source for germinating seeds.
IP₆ and other inositol phosphates (IP₁, IP₂, IP₃, IP₄, IP₅) is found in most mamalian cells where it assists in “regulating and normalizing ” a variety of important cell functions. IP₆ and other inositol phosphates (IP₁, IP₂, IP₃, IP₄, IP₅) is found in most mamalian cells where it assists in “regulating and normalizing” a variety of important cell functions.
Dr Abulkalam M. Shamsuddin, M.D., PhD, Professor of Pathology at the University of Maryland School of Medicine in Baltimore, first conducted experiments on the anti-cancer action of Inositol & Cal Mag IP₆. Dr. Shamsuddin combined Inositol & Cal Mag IP6, because in doing so, IP₆ would lose one or more phosphate (P) and could yield more crucial IP₃.

IP₃ is the key regulator of cell growth, therefore Inositol & Cal Mag IP₆ produce the maximum effect desired. IP₃ controls cell production and differentiation.
Inositol is recognized as part of the vitamin B complex group. Inositol is found in meats, citrus fruits, nuts, beans and whole grains. It is water soluble and not stored very well in the body. Thus an intake of inositol is needed daily to support many functions.

Only IP₆ with Inositol is a patented and proprietary ingredient that has over 70 studies conducted, to measure its powerful effects.
The properties found in Inositol & Cal Mag IP₆ are vital to human health in a variety of functions.
Inositol & Cal Mag IP₆ is more effective than high fiber diets! An enzyme called phytase is also found in the intestine and can actually break down and degrade IP₆, thus not allowing it’s desired effects on the body. Pure Inositol & Cal Mag IP₆ is much more effective, since it is absorbed before the enzyme has a chance to destroy it.

Enhanced Immune and Antioxidant Characteristics:

By binding up (chelating iron), IP₆ has the unique ability to remove O2 without allowing the formation of oxygen free radicals.

Natural Killer (NK) Cells

Play a central role in various aspects of the body’s defence system. In “In Vivo” laboratory studies using mice fed IP₆, greatly enhanced NK cell activity was measured, over untreated control groups*.

*(Baten et al., 1989.)

Cholesterol and Triglycerides

In elevated levels are major risk factors for atherosclerosis and coronary heart disease. In Vivo studies conducted on mice with enriched diets, had their cholesterol lowered by 19% and triglycerides by 65%, when IP-6 was added to the diet*. Other studies have shown that individuals with high cholesterol have higher levels of zinc in their system compared to copper. IP₆ actually normalizes the zinc to copper ratio. Other studies in animals have been shown to remove the calcification in arteries.

*(RAXIL JARIWALLA et al., 1990.)

Diabetes

Inositol deficiencies within the cells in patients with diabetes (such as altered sensations in nerves in hands and feet, cataract and retinal damage & early derangements in kidney functions). Dosages of Inositol, ranging from 0.5 grams twice daily to 3 grams/day have been given to patients with diabetic neuropathy*. Results to date support that oral supplementation of Inositol may benefit in the prevention and treatment of neural complications of “diabetes mellitus”.

*(HOLUB, 1986.)

Kidney Stones (Urolithiasis)

Most kidney stones are caused by an abnormal accumulation of calcium oxalate and calcium phosphate. It is known that 1-3% of total administered IP₆ is excreted in the human urine. Experiments have shown IP₆, IP₂& IP₃ are effective in preventing the formation of calcium crystals*. Thus a urinary content of inositol phosphates would effectively inhibit kidney stone formation. In the past diets containing high amounts of IP₆ (rice bran) have been used to treat kidney stones. It is easier to take a small amount of Inositol & Cal Mag IP₆ in tablet or capsule form.

*(Grases et al.,1995,1996A;1996B; Modiln,1980.)

Heart Disease

The strong antiplatelet activity indicates that IP₆ may reduce the risk of coronary heart diseases, and other diseases that result from blood clots forming and breaking off, such as ischemic strokes*.

*(Vucenik-I,Podcaczasy-J-J, Shamsubdin-A-M. Anticander Research 1999-Sep-Oct, Vol 19.)

Inflammation and Fibrosis

Fibrosis is the formation of fibrous tissue in the lungs as a reaction to an irritant such as asbestos. Because IP₆ can remove iron or inactive free radicals, it reduces the tissue damage during inflammation decreasing potential risk of DNA damage. Test on rats exposed to asbestos, showed significantly less fibrosis in the rat control group fed IP₆*.

*(Dr. David W. Kamp et al., 1995a, b).

Cancer Inhibition by Inositol & Cal Mag IP₆

Department of Medical Research Technology and Department of Pathology University of Maryland School of Medicine, Baltimore, MD 21201. Studies were conducted by Dr. Shamsuddin et al.

The striking anti cancer effect of Inositol & Cal Mag IP₆ was demonstrated in different experimental models.
In addition to reducing cell proliferation, IP₆ increases differentiation of malignant cells, often resulting reversion to normal phenotype.
Enhanced immunity and antioxidant properties of Inositol & Cal Mag IP₆ can also contribute to tumour cell destruction. However, the molecular mechanism underlying the anti cancer action are not fully understood. Because it is abundantly present in regular diet, efficiently absorbed from the gastrointestinal tract and safe, IP₆ holds great promise in our strategies for prevention and treatment of cancer.
Inositol & Cal Mag IP₆ enhance the anti cancer effect of conventional chemotherapy, controls cancer metastasis and improves the quality of life, as shown in a pilot clinical trial.

The data strongly argue for the use of Inositol & Cal Mag IP₆ in our strategies for cancer prevention and treatment. However, the effectiveness and safety of Inositol & Cal Mag IP₆ at therapeutic doses needs to be determined in Phase I and Phase II clinical trials in humans.